Cairo - Mubasher: Sabaa International Company for Pharmaceutical and Chemical Industry said it looks forward to raising its revenues to EGP 60 million in 2016.
The company's estimated revenues for 2015 stands at EGP 40 million.
The drug firm will start operating its powder production line before June 2016 at an investment cost of $87,000, said a bourse statement.
The company is also preparing to produce three major drugs in the first half of 2016.
Sabaa Pharmaceutical earlier reported net profits of EGP 1.6 million for the first nine months of 2015, compared with EGP 1.7 million a year earlier.
